Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Clobetasol propionate 0.05% ointment	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Very potent
Clobetasol propionate 0.05% scalp application	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Very potent
Clomifene tablets		Specialist recommendation - ovulation induction
Clonazepam tablets		MHRA Category 2: the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history
Clonidine tablets
Coal tar 5% lotion (Exorex®)
Co-beneldopa capsules
Co-beneldopa dispersible tablets
Co-beneldopa M/R capsules
Co-careldopa M/R tablets

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.